fingolimod hydrochloride has been researched along with Osteolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, X; Guo, Y; Li, Y; Wang, S; Wang, Y; Wang, Z; Yang, R; Zong, S | 1 |
| Chiba, K; Imayoshi, T; Matsuura, M; Okumoto, T | 1 |
2 other study(ies) available for fingolimod hydrochloride and Osteolysis
| Article | Year |
|---|---|
FTY720 Attenuates LPS-Induced Inflammatory Bone Loss by Inhibiting Osteoclastogenesis via the NF-
Topics: Animals; Bone Resorption; Fingolimod Hydrochloride; Histone Deacetylases; Lipopolysaccharides; Mice; Mice, Inbred C57BL; NF-kappa B; Osteoclasts; Osteogenesis; Osteolysis; RANK Ligand; Repressor Proteins | 2023 |
Effect of FTY720, a novel immunosuppressant, on adjuvant-induced arthritis in rats.
Topics: Animals; Arthritis, Experimental; Cyclosporine; Edema; Fingolimod Hydrochloride; Immunosuppressive Agents; Leukocyte Count; Lymphocytes; Male; Monocytes; Mycobacterium tuberculosis; Neutrophils; Osteolysis; Propylene Glycols; Rats; Rats, Inbred Lew; Sphingosine; Tacrolimus | 2000 |